复发性卵巢癌的二次肿瘤细胞减灭术：SGO临床实践声明 - Suppr | 超能文献

相似文献

1

Secondary cytoreductive surgery for recurrent ovarian cancer: An SGO clinical practice statement.复发性卵巢癌的二次肿瘤细胞减灭术：SGO临床实践声明

Gynecol Oncol. 2021 Dec;163(3):448-452. doi: 10.1016/j.ygyno.2021.10.008. Epub 2021 Oct 20.

2

Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer.细胞减灭术联合化疗与单纯化疗治疗复发性上皮性卵巢癌。

Cochrane Database Syst Rev. 2024 Jun 27;6(6):CD015297. doi: 10.1002/14651858.CD015297.

3

When should Surgery be used for Recurrent Ovarian Carcinoma?复发性卵巢癌何时应采用手术治疗？

Clin Oncol (R Coll Radiol). 2018 Aug;30(8):493-497. doi: 10.1016/j.clon.2018.04.006. Epub 2018 May 7.

4

Secondary cytoreduction surgery for recurrent epithelial ovarian cancer patients after PARPi maintenance: A multicenter, randomized, controlled clinical trial.PARPi维持治疗后复发性上皮性卵巢癌患者的二次肿瘤细胞减灭术：一项多中心、随机、对照临床试验。

Int J Gynecol Cancer. 2024 Feb 5;34(2):328-331. doi: 10.1136/ijgc-2023-004978.

5

[Ⅰ. Secondary Cytoreductive Surgery for Platinum-Sensitive Recurrent Ovarian Cancer -Review and Consideration from Recent International Phase Ⅲ Trials].[Ⅰ. 铂敏感复发性卵巢癌的二次肿瘤细胞减灭术——基于近期国际Ⅲ期试验的综述与思考]

Gan To Kagaku Ryoho. 2021 Feb;48(2):191-194.

6

Complete tumor resection and demonstration of detailed anatomy of the porta hepatis in a patient with recurrent epithelial ovarian cancer.对一名复发性上皮性卵巢癌患者进行肿瘤完整切除并展示肝门部的详细解剖结构。

Int J Gynecol Cancer. 2021 Jan;31(1):148-149. doi: 10.1136/ijgc-2020-002063. Epub 2020 Dec 10.

7

Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept.前瞻性手术与新辅助化疗后间隔减瘤手术治疗 IIIC 期和 IV 期卵巢癌患者的研究，SGOG SUNNY（SOC-2）试验方案。

J Gynecol Oncol. 2020 Sep;31(5):e86. doi: 10.3802/jgo.2020.31.e86.

8

Cytoreductive Surgery for Relapsed Ovarian Cancer.复发性卵巢癌的减瘤手术

N Engl J Med. 2022 Mar 3;386(9):896-897. doi: 10.1056/NEJMc2120128.

9

Effect of platinum sensitivity on the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in recurrent epithelial ovarian cancer.铂类药物敏感性对复发性上皮性卵巢癌腹腔热灌注化疗（HIPEC）疗效的影响。

J Gynecol Obstet Hum Reprod. 2021 May;50(5):101844. doi: 10.1016/j.jogoh.2020.101844. Epub 2020 Jun 23.

10

Incorporating robotic surgery into the management of ovarian cancer after neoadjuvant chemotherapy.将机器人手术纳入新辅助化疗后卵巢癌的治疗管理中。

Int J Gynecol Cancer. 2019 Nov;29(9):1341-1347. doi: 10.1136/ijgc-2019-000413. Epub 2019 Oct 9.

引用本文的文献

1

Elucidating the role of fatty acid reprogramming in ovarian cancer: insights cross-talk between blood, subcutaneous fat, and ovarian cancer tissues.阐明脂肪酸重编程在卵巢癌中的作用：血液、皮下脂肪和卵巢癌组织之间的相互作用见解

Front Oncol. 2025 Apr 30;15:1530487. doi: 10.3389/fonc.2025.1530487. eCollection 2025.

2

Secondary cytoreductive surgery in platinum-sensitive relapsed ovarian cancer: a meta-analysis of randomized controlled trials.铂敏感复发性卵巢癌的二次细胞减灭术：随机对照试验的荟萃分析

Arch Gynecol Obstet. 2025 Feb;311(2):405-414. doi: 10.1007/s00404-024-07863-x. Epub 2024 Dec 16.

3

Morbidity after secondary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for ovarian cancer: An analysis of a randomized phase II trial.